Non-opioid dynorphin binding site on secretory vesicles of a pituitary-derived cell line (Q41033484)

25 September 2017

title

Non-opioid dynorphin binding site on secretory vesicles of a pituitary-derived cell line (English)

1 reference

25 September 2017

0 references

Yarygin KN

1

1 reference

25 September 2017

Zhang XH

series ordinal

2

1 reference

25 September 2017

Lee NM

series ordinal

3

1 reference

25 September 2017

publication date

1 April 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

791

1 reference

25 September 2017

issue

1-2

1 reference

25 September 2017

page(s)

99-107

1 reference

Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

A non-opioid pattern characterizes inhibition of growth hormone releasing peptide binding by dynorphin-related peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Interactions of dynorphin A and related peptides with cardiac ouabain binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Cardiovascular effects of microinjection of dynorphin fragments into the nucleus of the solitary tract (NTS) are mediated by non-opioid mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Cysteamine inhibition of prolactin immunoassayability and secretion: studies with aminothiophenols and other analogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Calcium Release from Pituitary Secretory Granules: Modulation by Thiols, Disulfides, and Dihydropyridine Calcium Channel Blockers*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Isolation and characteristics of bovine pituitary secretory granules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Dynorphin peptides: antagonists of melanocortin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Characterisation of the melanocortin 4 receptor by radioligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Non-opioid effects of dynorphins: possible role of the NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

Suppression of withdrawal symptoms by dynorphin in heroin addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900084-5

10.1016/S0006-8993(98)00084-5

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference